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Background: We analyzed the embolectomy results and complications of patients who were 
operated on after a diagnosis of late acute arterial occlusion of lower extremities.
Methods: A total of 122 patients operated on in our clinic between 2004 and 2009 for late acute 
arterial occlusion were included in the study. Late arterial occlusion was defined as occlusion 
occuring 72 hours after initial manifestation of the patient complaints related to the affected 
lower extremity.
Results: Average age of the 122 patients (71 male, 51 female) was 54.2 ± 16.8 years. In this 
cohort, 64.75% of patients had cardiac pathologies, while 28.68% had extracardiac causes; 1.64% 
patients had cathetherization, 0.81% patient had malignancy, and 2.46% patients had a history of 
trauma. In 1.64% of the cases, no reason for thromboembolysis could be found. Thirty-one patients 
(25.40%) had additional surgical operations, 14 (11.47%) had fasciotomy, and 9 (7.37%) had 
amputation. Re-embolectomy was performed on 37 patients (30.32%) who had ongoing ischemia 
after an operation. Additional surgical operations were performed on 31 patients (25.40%) with 
ongoing ischemia. In 14 of these cases (11.47%), patients were treated with fasciotomy due to 
development of compartment syndrome. Amputation was performed on a total of 9 patients. 
Early in the postoperative phase, mortality was observed in 11 patients (9.01%).
Conclusion: We believe that late embolectomies of acute late leg ischemia increases blood 
flow in the extremity and reduces the number of amputations required.
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Introduction
Critical leg ischemia can be observed as an acute event that is either the initial finding 
of peripheral arterial disease for a patient or the reason for symptomatic deterioration 
in a patient with peripheral arterial disease of the lower extremities (intermittent 
claudication). Since some cells are more sensitive to anoxia, it is very difficult to 
determine the tolerance of extremities to ischemia. After 4 to 6 hours of ischemia, 
irreversible changes arise in skeletal muscles and peripheral nerves.
In acute arterial occlusive disease, rapid diagnosis and performing the appropriate 
treatment with a multidisciplinary approach are critically important. Nevertheless, 
despite the progress in treatment and techniques, amputation and mortality rates 
have remained high, even in special/private vascular surgery centers.1 Late use of 
embolectomy on an extremity with ischemia remains controversial, but has been 
gaining acceptance.
It is known that a delay of more than 8 hours increases ischemic complications 
in patients with arterial emboli in an extremity. On the other hand, the literature Vascular Health and Risk Management 2009:5 622
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shows a decrease in appearance of complications when 
the period of ischemia exceeds 7 days.2 In light of this 
observation, it can be inferred that performance of a 
surgical operation after the patient has survived the first 
week of ischemia with little extremity or tissue loss could 
be more successful. In this clinical study, our aim was to 
analyze retrospectively the results of arterial embolec-
tomies and complications in patients, who are admitted 
to surgery with diagnosis of late acute lower extremity 
arterial occlusion.
Materials and methods
A total of 122 patients who were admitted to our clinic 
with diagnosis of late acute lower extremity arterial 
occlusion and who were operted on between January 2004 
and February 2009 were included in the study. Computer 
records of these patients were retrospectively analyzed 
and recorded.
Late arterial occlusion is defined as occlusion occuring 
72 hours after initial manifestation of patient complaints 
related to the effected lower extremity. Only the patients 
who met this criterion were included in this study. 
We excluded the patients with polytrauma because we 
thought that it may negatively affect mortality and morbidity. 
In all cases, diagnosis was made by the use of anamnesis, 
physical examination, and doppler ultrasonography; we 
employed no additional tests, such as conventional angiog-
raphy or CT angiography, to any patients prior to surgery. 
No intraoperative angiography was performed on any 
patient, but all patients duplex examiniation was performed 
on all patients in the preoperative period.
When examining the patients, we sought answers to 
three questions: is the extremity still viable? Is the viability 
of the extremity acutely threatened? Are there irreversible 
changes that hinder preservation of the extremity? All of 
the patients were analyzed according to the Turkish Society 
of Vascular Surgery classification scheme (Table 1).3 
Nonetheless, we performed advanced tests on those patients 
whose ischemia were not treated with embolectomy and 
who had planned reoperations. After embolectomy, all the 
patients were examined with abdominal ultrasonography 
and cardiac ecocardiography to investigate the origin of the 
arterial occlusion.
surgical method
Femoral arterial embolectomies of the lower extremities 
were performed under local anesthesia by a longitudinal 
incision from the femoral region. Spinal anesthesia was 
used for patients that had popliteal embolectomy and 
additional surgical operation. Standard 3F, 4F and 5F 
Fogarty embolectomy catheters were used. 3F and 4F Fogarty 
catheters were used for distal embolectomy while 5F Fogarty 
catheters were used for proximal embolectomy.
The embolectomy was stopped when the thrombus was 
completely removed from distal and proximal approaches 
(when the thrombus could not be contacted distally or 
proximally by a Fogarty catheter), and distal backflow and 
proximal flow was deemed adequate. In all cases, arteriotomy 
was closed by washing the distal bed with 5000 U of heparin 
diluted in 100 mL of 0.9% physiological saline solution. 
For patients with ongoing ischemia despite embolectomy, 
additional surgery was performed after CT angiography or 
conventional angiography (Table 2).
Preoperative and postoperative medical 
treatment protocol
For all patients diagnosed with arterial occlusion, heparin-
dextran 40-pentoxyphillin infusion was administered and 
continued for 3 days postoperatively. Conventional heparin 
was started at a dose of 100 U/kg/h and dextran 40 at 
0.5 mL/kg/h. Heparin was assessed with ACT (activated 
coagulation time). ACT level was maintained within the 
range of 200 to 300 seconds. Following this, patients were 
administered anticoagulants.
statistical analysis
SPSS Windows 10.0 statistical software package was used for 
analyzing patient records. Continuous variables are presented 
as means ± standard deviation. Student’s test, Chi-square 
Table 1 Assessment of viability of the extremity
  Description/
Prognosis
Sensory loss Functional failure 
in muscle
Arterial doppler 
signals
Venous doppler 
signals
stage 1:   Viable no urgent threat no no Yes Yes
stage 2a: Marginal threat can be saved Minimal (fingers) no Yes Yes
stage 2b: serious threat can be saved urgently Extensive Mild-moderate no Yes
stage 3: Irreversible Inevitable tissue loss Anesthesia Paralysis no noVascular Health and Risk Management 2009:5 623
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and Fisher’s exact tests were used. A P value 0.05 was 
considered as statistically significant.
Results
Average age of the 122 patients (71 male, 51 female) operated 
on was 54.2 ± 16.8 years. Preoperative demographic data 
of the patients are presented in Table 3. We observed that 
peripheral arterial occlusions were frequently caused by 
cardiac pathologies. Cardiac-related reasons were present 
in 79 cases (64.75%) (atrial fibrilation in 46 cases, mitral 
stenosis in 5 cases, mitral stenosis and atrial fibrillation in 
14 cases, prosthetic cardiac valves in 4 cases, myocardial 
infarction history in 9 cases, endocarditis in 1 case); 
extracardiac reasons were present in 35 cases (28.68%) 
(atherosclerosis in 24 cases, vascular trauma in 4 cases, 
abdominal aort aneurism in 7 cases); catheterization in 
2 cases (1.64%); malignancy in 1 case (0.81%); and history 
of trauma in 3 cases (2.46%). In 2 cases (1.64%) no reason 
could be found to explain the thromboembolysis.
Re-embolectomy was performed on 37 patients (30.32%) 
that had ongoing ischemia after an operation. Additional 
surgical operations were performed on 31 patients (25.40%) 
with ongoing ischemia (Table 2). In 14 of these cases 
(11.47%), patients were treated with fasciotomy due to 
development of compartment syndrome. Amputation 
was performed on a total of 9 patients (7.37%) who had 
life-threatening risks; these included 7 patients who had 
ongoing ischemia despite fasciotomy and had developed a 
demarcation line, and 2 patients with graft infections. Seven 
of the amputations were above and 2 were below the knee.
Incision site infections were observed in 11 of the patients 
(9.01%). Infections developed at the amputation site in 
2 patients, in the popliteal region below the knee in 2 patients, 
at abdominal incision site in 1 patient, and 3 patients had 
graft infections. Two patients with graft infections had 
amputations performed and the other patients were treated 
with antibiotherapy. Among the less common complications, 
myonephropathic metabolic syndrome (reperfusion damage) 
occurred in 5 patients (4.09%), and venous thrombosis in 
3 patients (2.45%).
Mortality was observed early in the postoperative period 
in 11 patients (9.01%). The cases of mortality comprised 
patients who were notably older (64.3 ± 5.26 years), mostly 
with cardiac problems. However, the age difference between 
cases with and without mortality was not statistically 
significant (P  0.05). When patients were admitted to the 
hospital after 72 hours, mortality was not affected by whether 
they were admitted between 3 and 7 days or after 7 days 
(P  0.05). However, morbidity was significantly higher 
for patients admitted after 7 days (P = 0.027). Demographic 
features related to morbidity and mortality are presented on 
Table 4.
Table 2 surgical operations and occlusion levels
  N %
Surgical operations
Femoral embolectomy 88 72.13
Popliteal embolectomy 21 17.21
Femoral + popliteal embolectomy 13 10.65
Additional surgical operations
Aortafemoral bypass 7 5.73
Iliofemoral bypass 5 4.09
Femorofemoral bypass 7 5.73
Femoropopliteal bypass 12 9.83
Occlusion level
Aortic bifurcation 7 5.73
Iliac 12 9.83
Femoral 78 63.93
Popliteal 25 20.49
Table 3 Preoperative demographic data
  N %
Age (average) 54.2 ± 16.8
Sex (male/female) 71/51 58.19/41.80
Accompanying diseases
Diabetes mellitus 28 22.95
Hypertension 31 25.40
Atrial fibrillation 60 49.18
congestive heart failure 9 7.37
Rheumatismal heart disease 23 18.85
cerebrovascular disease 3 2.45
Ischemic heart disease 13 10.65
Onset of complaints
3–7 days 91 74.59
7 days 31 25.40
Admittance complaints
Pain 114 93.44
coldness 88 72.13
Paleness 94 77.04
sensory loss 12 9.83
Motor deficit 4 3.27
cyanosis 13 10.65Vascular Health and Risk Management 2009:5 624
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Discussion
We analyzed patients admitted to our clinic with acute arterial 
occlusion who have been operated on in the last 5 years. 
Delayed use of embolectomy on the extremity with ischemia 
is still controversial. However, it has been gaining acceptance. 
Studies in which clinical and pathological data of late arterial 
embolectomies are investigated have shown that there are 
four major factors for successful treatment: 1) relatively less 
damage on arterial intima; 2) thrombus not adhering to intima 
and no secondary thrombus on intima; 3) patent distal arterial 
tree despite embolization; and 4) presurgical treatment with 
anticoagulants. When these factors are maintained, adequate 
circulation can be achieved in the extremities of patients with 
the use of delayed embolectomy.4
Critical leg ischemia is defined as a sudden decrease in 
leg perfusion, which threatens viability of the extremity. 
This condition not only results in local ischemia, but also to 
a pathology that can lead to systemic complications. It is the 
reason for 10% to 15% of surgeries performed in vascular 
surgery clinics and involves 5% to 7% of patients admitted 
to these clinics with vascular symptoms.5
Despite the improved intensive care and surgical 
conditions, mortality rates remain high.6 Mortality and 
morbidity risks persist even when the reason for acute 
ischemic condition is eliminated and reperfusion is attained. 
When surgical intervention is delayed, these risks increase.7 
Approximately a hundred years have passed since the first 
successful embolectomy performed by Georges Labey in 
1911.8 The embolectomy catheters devised by Fogarty have 
facilitated this operation and increased its success.9
Our classical knowledge states that the earlier the 
embolectomy (especially when it is within the first 8 hours), 
the better the result. However, cases of successful embolec-
tomies performed a few days after an acute occlusion have 
also been reported.2,10–12 Eliot et al2 showed that for patients 
with arterial emboli, a delay of more than 8 hours increases 
ischemic complications, but when the delay exceeds 7 days, 
the occurrence of complications decreases.
On the other hand, Blaisdell et al13 findings contradict 
those of Eliot and suggests that a single high-dose heparin 
therapy course be employed (starting with a 20,000 U bolus 
and continuous perfusion of 2000 to 4000 U/h). According 
to his view, embolectomy should be performed only on 
patients with less than 8 hours of ischemia, who are low 
risk. Cardiac diseases, most commonly mitral narrowness 
and atrial fibrillation, are the reason for 80% to 90% of acute 
arterial emboli. Embolus is found on the left ventricle apical 
thrombus, which forms after anterior transmural infarction, 
at a rate of 5%. Cardiac mixoma, mechanical heart valves, 
and grafts are other possible reasons for emboli.14,15 Farshad 
et al16 stated that 10% to 15% of emboli as not cardiac-related. 
Cranley et al17 could not find the cause for emboli in 10% of 
the cases. However, in our study, the causes for the emboli 
were 64.75% cardiac, 28.68% extracardiac, and 9.04% other 
reasons; and, unlike Cranley et al, we could not find the 
reason for emboli in only 2 cases (1.63%).
Compartment syndrome caused by reperfusion after 
embolectomy must be carefully assessed. Early fasciotomy 
is required to prevent ischemia and complications that may 
occur. The time between the onset of ischemia and treatment, 
the cause of embolization, localization of the emboli, and 
accompanying pathologies are reported to be important for 
therapeutic success.18
Free oxygen radicals, which emerge after re-establishment 
of blood flow in an extremity that has remained ischemic for 
a long time, interact with endothelium and neutrophils, and 
rapidly increase lipid peroxidation, resulting in many local 
and systemic affects. Cellular swelling, edema, toxin and 
myoglobulin release, accompanied by the effects of free 
oxygen radicals may cause systemic damages such as acute 
kidney failure, lung edema, sudden onset of adult respiratory 
distress syndrome and liver shock. Even when extremity 
reperfusion has been completely restored by removal of the 
underlying cause of the acute ischemic condition, a chain 
of events may result in loss of the extremity, acute kidney 
Table 4 Demographic data related to morbidity and mortality
  N %
second time embolectomy 37 30.32
Third time embolectomy 9 7.37
Complications
Fasciotomy 14 11.47
Amputation 9 7.37
Infection 11 9.01
Myonephropathic metabolic syndrome 5 4.09
Venous thrombosis 3 2.45
Mortality 11 9.01
Causes of mortality
Myocardial infarction 3 2.45
congestive heart failure 2 1.63
cerebral emboli 1 0.81
Kidney failure 1 0.81
Multiorgan failure 2 1.63
Arrhythmia 1 0.81
gastrointestinal bleeding 1 0.81Vascular Health and Risk Management 2009:5 625
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and respiratory failure, or functional deterioration in tissues 
such as heart, intestine, brain or spleen.19 This “reperfusion 
damage”, or “myonephrotic metabolic syndrome” as 
suggested by Haimovici, is the main cause of mortality and 
morbidity especially in acute cases treated late.20
In various studies, systemic organ damage has been 
shown to appear as a result of ischemia in the skeletal 
muscle after 6 to 8 hours of ischemia and as a result of the 
production of ischemic metabolites, myoglobulinemia and 
myoglobulinurea, after revascularization.19–22 Aune et al23 
reported that both serious cardiac disease and reperfusion 
damage increase mortality in cases of embolism. In our study, 
5 patients developed myonephrotic metabolic syndrome by 
production of ischemic metabolites, and by myoglobinemia 
and myoglobulinurea, after revascularization. However, 
we were prepared for this complication and had taken the 
necessary precautions and immediately started dialysis. 
Among these 5 patients, only 1 was lost.
The amputation rate following operations undertaken 
during the first 12 hours is reported in the range of 2.1% 
to 5.9%; but the rate increases to 39.2% after 12 hours.16,17 
Mortality rates have reported as 12.5% within 12 hours 
and 37.7% thereafter.24 Hight et al25 analyzed 11 different 
series between 1954 and 1974 and determined an amputation 
rate of 4% to 48% and a mortality rate of 14% to 50%. 
In a study by Yangni et al26 that included 24 patients, the 
amputation rate was reported as 29.2% and the mortality 
rate as 29.2%. In another study, the amputation rate of 
arterial embolectomies beyond 24 hours was reported to 
be 11.4%.15
In our study, fasciotomy was performed for 11.47% of the 
patients, those who had developed compartment syndrome. 
For 7 patients who had ongoing ischemia despite fasciotomy 
and who had developed a demarcation line and for 2 patients 
with graft infections, amputation was performed (altogether 
7.37%) because of life-hreatening risks. Although mortality 
rates of patients who have received embolectomy 12 hours 
later is reported to be high in the literature, only 11 patients 
died (9.01%) in our study, mostly older (average age, 
64.3 ± 5.26 years) patients, mostly with cardiac problems. In 
addition, we think that postoperative heparin and dextran 40 
infusion for at least 3 days is the reason for the lower morbid-
ity and mortality rates observed in our study cohort.
Early diagnosis and treatment of acute arterial emboli 
play an important role in morbidity and mortality. Consider-
ing our morbidity and mortality rates, we think that perform-
ing an additional surgical operation in acute leg ischemia 
would be appropriate even if a week has passed.
Conclusion
We believe that late embolectomies of acute leg ischemia 
increase blood flow in the extremity and reduce the number 
of amputations required. We also think it is advantageous 
to give the patient a chance by performing embolectomy, 
even as late as a week after diagnosis of ischemia.
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